4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001104659-22-031596
Director bought 647,264 shares at an average $12.74 ($8,248,255)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-04 | Purchase | +63,662 | $12.99 | $827,230 | 11,578,944 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-07 | Purchase | +337,901 | $12.61 | $4,260,965 | 11,916,845 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-03-08 | Purchase | +245,701 | $12.86 | $3,160,059 | 12,162,546 | I |
| Open-market purchases · 647,264 sh · avg $12.74 · $8,248,255 | |||||||
Loading xslF345X03/tm228693-1_4seq1.xml…